Advertisement

Topics

UroGenRA - Genitourinary cancer array - Biotech, Pharma and Life Science Channel

22:59 EST 21st November 2017 | BioPortfolio

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It was designed to detect gains and losses that frequently occur in these three cancer types and that have the potential to differentially diagnose and/or stratify patients to assist and guide clinical management. For kidney cancer, it is specifically designed to classify tumors into the four main types (three malignant, one benign) critical at several levels in patient management: diagnosis of image-guided needle biopsies of small incidentally discovered kidney masses providing rationale for surgical/non-surgical management,  diagnosis in patients with larger neoplasms to stratify for risks of local or regionally advanced disease that can be factored in to treatment selection recommendations (i.e., extent of surgical intervention, less invasive options or ablation), in those with metastatic disease, where drug trials are currently based on post-surgical tumor diagnosis, and potentially in the diagnosis of the so-called morphologically “unclassified” renal cancers. Additionally within the predominant subtype, clear cell renal cell carcinoma, prognostication is feasible based on the presence/absence of gain and loss of certain genomic regions. For prostate cancer, UroGenRA, has the potential to assess prostate core/needle biopsy genomic variability, to identify biomarker for inclusion in nomograms for assessment of risk of biochemical recurrence, to assess radiocurability and treatment options for intermediate risk patients, and to explore the genomic aberrations of circulating tumor cells. For bladder cancer, UroGenRA has application in identifying tumors most likely to recur, and of muscle-invasive lesions those most likely to benefit from treatment.

Source: http://cancergenetics.com/cgi-research/cgh-microarray/ UroGenRA is a Registered Trademark of CGI

PubMed Articles [15298 Associated PubMed Articles listed on BioPortfolio]

Targeted secondary metabolic and physico-chemical traits analysis to assess genetic variability within a germplasm collection of "long storage" tomatoes.

"Long storage" tomato is a crop traditionally cultivated in the Mediterranean area under no water supply, that recently has attracted the interest of breeders for its high tolerance to drought and as ...

Thoracic Surgery in the Pregnant Patient.

Thoracic surgeons are sometimes asked to consult on the management of a patient who is pregnant. Conditions commonly encountered are empyema, spontaneous pneumothorax, and diaphragmatic hernia. Lung c...

Lung Cancer and Lung Transplantation.

Lung transplantation remains a viable option for patients with endstage pulmonary disease. Despite removing the affected organ and replacing both lungs, the risk of lung malignancies still exists. Reg...

Management of Lung Cancer with Concomitant Cardiac Disease.

This article discusses the numerous issues surrounding lung cancer treatment in patients with concomitant cardiac disease. It also addresses the preoperative work-up of these patients and the specific...

Esophagectomy After Weight-Reduction Surgery.

Obesity is now epidemic worldwide, and an increasing number of patients have undergone a weight-loss procedure. Although obesity is a risk factor for esophageal cancer, there are few reports on esopha...

Thoracic Surgery in Early-Stage Small Cell Lung Cancer.

Small cell lung cancer (SCLC) has a complex history and remains difficult to treat. Most patients with SCLC present with metastases or extensive stage disease, rendering most not amenable to surgical ...

Management of Malignant Lung Entrapment, the Oncothorax.

Pleural metastasis is a common occurrence in up to 30% of patients with metastatic cancer. When lung entrapment and loculation of fluid occur, treatment is more difficult and we have named this condit...

Synchronous Esophageal and Lung Cancer.

Synchronous lung and esophageal cancers are rare but represent a unique challenge to thoracic surgeons. The literature is limited but series describe long-term survival with curative surgery for conco...

Empyema from Obstructing Lung Cancer.

Pleural collections on the side of an obstructing bronchial cancer pose a particular challenge. All efforts should be placed into determining whether the collection is malignant or para-malignant with...

Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.

Breast cancer is the most common cancer among women worldwide, and survival rates are increasing. Chemotherapy-associated peripheral neuropathy (PN) is clinically important because of effects on quali...

News Articles [11145 Associated News Articles listed on BioPortfolio]

Society for Immunotherapy of Cancer (SITC) Spearheads Initiative to Align Management of Immunotherapy Side-Effects

The first consensus recommendations on recognition and clinical management of immune-related side-effects from cancer immunotherapy are published today in the Journal for ImmunoTherapy of Cancer (JITC...

[Articles] Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals

Despite a moderate decline in standardised incidence of heart failure, the burden of heart failure in the UK is increasing, and is now similar to the four most common causes of cancer combined. The ob...

Fluidigm Corp FLDM Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryFluidigm Corp Fluidigm formerly known as Mycometrix Corporation, is a biotechnology company which manufactures lifescience tools and creates technologies based on microfluidics and mass cytomet...

Evidence from 1970 on sugar’s effects on health never saw light of day

A sugar industry research group had evidence of an association between sucrose consumption and cardiovascular disease and bladder cancer nearly a half century ago, researchers have found, but the... ...

Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.

Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent i...

OncLive® and The Ruesch Center to Honor the Winners of The Luminary Awards in GI Cancers

Honorees are recognized for their continuous support of the gastrointestinal cancer community The inaugural Luminary Awards in GI Cancer, which will be hosted by OncLiv...

SHAREHOLDER ALERT: Bronstein, Gewirtz Grossman, LLC Announces Investigation of Array Biopharma, ...

On March 19, 2017, Array issued a press release announcing the withdrawal of the New Drug Application ("NDA") for the Company's cancer drug binimetinib, stating Read more...

New Application Note from BMG Labtech

The fluorescent probe NR12S detects changes in plasma membrane cholesterol levels The cell membrane is a bilayer of phospholipids with embedded proteins. It contains cholesterol that determines the me...

Medical Food Firm's Production Investigated After Rash Of Adverse Events

FDA receives 194 adverse event reports regarding Primus Pharmaceuticals''s Limbrel medical food capsules, including two about "potentially life-threatening medical conditions."......

Nearly half of U.S. cancer deaths blamed on unhealthy behavior

A new study finds that 45 percent of cancer deaths and 42 percent of diagnosed cancer cases could be attributed to "modifiable" risk factors.

Events [0 Results]

None

Companies [712 Associated Companies listed on BioPortfolio]

Cigna Corporation and Good Samaritan Health System

The Good Samaritan Health System, which includes Regional Medical Center of San Jose and Good Samaritan Hospital-as well as three surgical centers and three Care Now Urgent Care c...

Universal Diagnostics

Universal Diagnostics (UDX) is an innovative biomedicine company focused on early detection of cancer. By combining world-leading expertise in metabolomics with advanced bioinform...

Friends of Cancer Patients (FoCP)

CURE Connections®

A subsidiary of CURE Media Group, CURE Connections® provides a video platform for patients with cancer to share information, stories and advice about their cancer journey. CURE...

OncoResponse

OncoResponse discovers and develops highly targeted and immuno-oncology therapeutic antibodies against novel cancer targets. Our most advanced program, ONCR-201 is an anti-EMP2 fu...

EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The ...

Gateway for Cancer Research

CBT Pharmaceuticals

CBT Pharmaceuticals is a life sciences company developing innovative oncology therapeutics targeting the growth and proliferation of cancer cells. The company is advancing a pipel...

GeneCentric Therapeutics

GeneCentric Therapeutics is applying proprietary technology to identify drug responder populations that enable development of precision medicine drugs and improve patient outcomes...

Translational Drug Development (TD2) and Minneamrita Therapeutics LLC

Minneamrita is an early clinical stage drug development company developing the molecules for unmet cancer treatments. Minneamrita is developing Minnelide for its use in various ca...

Clinical Trials [6795 Associated Clinical Trials listed on BioPortfolio]

Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers

The goal of this clinical research study is to determine whether the PD-1 inhibitor (Programmed cell death protein 1) nivolumab improves premalignant bronchial dysplastic lesions in subjec...

Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention

The project aims to increase HPV vaccination and cervical cancer screening through a web-based mobile health education program called, Wheel of Wellness (WoW) and a brief negotiated interv...

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

PURPOSE: To determine the prognostic properties of a comprehensive evaluation of body composition and physical function in patients with GI-HEP cancer from point of diagnosis and throughou...

MRI of Esophagus Cancer

The role of MRI in the management of esophageal cancer remains unclear and poorly studied. Recent technical advances suggest that MRI may become a powerful technique for the initial assess...

A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer

30 patients with advanced colorectal cancer will be enrolled to observe the efficacy and safety of raltitrexed combined with apatinib as a third-line treatment.

Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

This randomized phase II trial studies how well enzalutamide with or without radium Ra 223 dichloride in treating patients with castration-resistant prostate cancer that has spread to othe...

Blood Test for Early Detection of Breast Cancer Using TM-B1

Blood samples from a total of 200 women in two cohorts will be collected and analyzed by TM-B1 assay, which is based on TBIA (Total Biochemical Infrared Analysis) to confirm the presence o...

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

A study to compare the efficacy, safety and immunogenicity of Leucostim® to those of Neupogen® in patients with breast cancer intended to be treated with TAC regimen as a myelosuppressiv...

Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors

Development and evaluation of an online intervention addressing sexual functioning in MSM after prostate cancer treatment.

Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients

Safety and tolerability of combination of Nivolumab and Ipilimumab will be studied in patients with 3 different types of cancers in 3 parts of the study, as shown below: Part 1 - Neoadjuv...

Videos

None available.

Medical and Biotech [MESH] Definitions

The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.

A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.

A contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. The condition is marked by the combination of WILMS TUMOR; ANIRIDIA; GENITOURINARY ABNORMALITIES; and MENTAL RETARDATION.

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...

review and buy UroGenRA - Genitourinary cancer array market research data and corporate reports here

Channels Quicklinks